2019-20 National Survey on Drug Use and Health (NSDUH) - CVS and FT

Forms and Documents

Document Name	Status
Form Screening Form Household Screening Form and Instruction	Modified
Form CVS Follow-up Clinical Interviews Form and Instruction	New
Form CVS Follow-up Clinical Certification Form and Instruction	New
Form CATI Verification Interview Verification Form and Instruction	Modified
Form CATI Verification Screening Verification Form and Instruction	Modified
Form Survey Interview Form and Instruction	Modified
2019 NSDUH SS_Part A_2020_CVS_FT REVISIONS 8.30.2019.docx Supporting Statement A	2019-09-17
2019 OMB Addendum_FT memo_FINAL 09 09 2019.docx Supplementary Document	2019-09-17
2019 OMB Addendum_CVS memo_ FINAL 09 04 2019.docx Supplementary Document	2019-09-17
Redesign Field Test_PDF 12_Attachment 1.pdf Supplementary Document	2019-09-17
Redesign Field Test_PDF 11_Attachment 17.pdf Supplementary Document	2019-09-17
Redesign Field Test_PDF 10_Attachment 10.pdf Supplementary Document	2019-09-17
Redesign Field Test_PDF 9_Attachment 12.pdf Supplementary Document	2019-09-17
Redesign Field Test_PDF 8_Attachment 19.pdf Supplementary Document	2019-09-17
Redesign Field Test_PDF 7_Attachments 5 13.pdf Supplementary Document	2019-09-17
Redesign Field Test_PDF 6_Attachments 15 16.pdf Supplementary Document	2019-09-17
Redesign Field Test_PDF 5_Attachment 14.pdf Supplementary Document	2019-09-17
Redesign Field Test_PDF 4_Attachments 7 8.pdf Supplementary Document	2019-09-17
Redesign Field Test_PDF 3_Attachments 9 11.pdf Supplementary Document	2019-09-17
Redesign Field Test_PDF 2_Attachment 2.pdf Supplementary Document	2019-09-17
Redesign Field Test_PDF 1_Attachments 3 4 6 18.pdf Supplementary Document	2019-09-17
2020 Main Study_PDF 13_Attachment Z AA.pdf Supplementary Document	2019-09-17
2020 Main Study_PDF 12_Attachment X Y.pdf Supplementary Document	2019-09-17
2020 Main Study_PDF 11_Attachment T.pdf Supplementary Document	2019-09-17
2020 Main Study_PDF 10_Attachment I.pdf Supplementary Document	2019-09-17
2020 Main Study_PDF 9_Attachments H U W.pdf Supplementary Document	2019-09-17
2020 Main Study_PDF 8_Attachment P.pdf Supplementary Document	2019-09-17
2020 Main Study_PDF 7_Attachments J K.pdf Supplementary Document	2019-09-17
2020 Main Study_PDF 6_Attachments A L S.pdf Supplementary Document	2019-09-17
2020 Main Study_PDF 5_Attachment N.pdf Supplementary Document	2019-09-17
2020 Main Study_PDF 4_Attachments D R.pdf Supplementary Document	2019-09-17
2020 Main Study_PDF 3_Attachments E O V.pdf Supplementary Document	2019-09-17
2020 Main Study_PDF 2_Attachment B.pdf Supplementary Document	2019-09-17
2020 Main Study_PDF 1_Attachments C F G M Q.pdf Supplementary Document	2019-09-17
Clinical Validation Study_PDF 4_Attachments 6 8 9 10.pdf Supplementary Document	2019-09-17
Clinical Validation Study_PDF 3_Attachments 3 4 5 11 12 13 14 15 16.pdf Supplementary Document	2019-09-17
Attachment AA 2019 Main Study Modules.docx Supplementary Document	2019-03-11
2019 NSDUH SS_Part B_2020_CVS_FT REVISIONS 8.30.2019.docx Supporting Statement B	2019-09-17
2019 NSDUH_PDF 9_attachments H U W.pdf Supplementary Document	2018-05-29
2019 NSDUH_PDF 8_attachment P.pdf Supplementary Document	2018-05-29
2019 NSDUH_PDF 7_attachment J K.pdf Supplementary Document	2018-05-29
2019 NSDUH_PDF 6_attachment A L S.pdf Supplementary Document	2018-05-29
2019 NSDUH_PDF 5_attachment N.pdf Supplementary Document	2018-05-29
2019 NSDUH_PDF 4_attachments D R.pdf Supplementary Document	2018-05-29
2019 NSDUH_PDF 3_attachments E O V.pdf Supplementary Document	2018-05-29
2019 NSDUH_PDF 1_attachments C F G M Q.pdf Supplementary Document	2018-05-29

IC Document Collections

IC ID	Document Title	Status
43643	Household Screening Form and Instruction	Modified
237757	Follow-up Clinical Interviews Form and Instruction	New
237756	Follow-up Clinical Certification Form and Instruction	New
195362	Interview Verification Form and Instruction	Modified
195361	Screening Verification Form and Instruction	Modified
195358	Interview Form and Instruction	Modified

ICR Details

OMB Control No: 0930-0110	ICR Reference No: 201909-0930-001
Status: Active	Previous ICR Reference No: 201901-0930-002
Agency/Subagency: HHS/SAMHSA	Agency Tracking No: 19864
Title: 2019-20 National Survey on Drug Use and Health (NSDUH) - CVS and FT
Type of Information Collection: Revision of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved with change	Conclusion Date: 10/24/2019
	Date Received in OIRA: 09/18/2019
Terms of Clearance: SAMSHA may use the non-substantive change mechanism to 1) incorporate the results of testing and 2) to modify existing questions for use in 2021, including those designed to add depth/additional detail and cycle in and out methodological modules that have been used in the past years (with modest updates). If new supplemental modules, new questionnaire instruments, or modifications to the sample or recruitment methods (other than those tested in the Field Test) are anticipated, a full revision of the ICR package must be submitted to OMB.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	10/31/2022	36 Months From Approved	03/31/2022
Responses	459,793	0	218,980
Time Burden (Hours)	219,105	0	79,852
Cost Burden (Dollars)	0	0	0

---

Abstract: The NSDUH (formerly the National Household Survey on Drug Abuse) is a survey of the civilian, noninstitutionalized population of the United States, age 12 and over. The data are used to estimate the prevalence of cigarette, alcohol and illicit drug use, and abuse of licit drugs. Results are used by SAMHSA, ONDCP, and other Federal agencies and other researchers and organizations to establish policy, direct program activities, and better allocate resources.

---

Authorizing Statute(s): US Code: 42 USC 505 Name of Law: Data Collection
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	84 FR 27341	06/12/2019
30-day Notice:	Federal Register Citation:	Citation Date:
	84 FR 40077	08/13/2019
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 6

IC Title	Form No.	Form Name
Household Screening	Screening Form, Screening Form, Redesign Field Test	Screening and Instruction ,   Screening and Instruction ,   Redesign Field Test
Interview	Redesign Field Test , Survey, Survey	Survey ,   Survey ,   Redesign Field Test
Screening Verification	CATI Verification Scripts, CATI Verification Scripts, CATI Verification Scripts	CATI Verification Scripts ,   CATI Verification Scripts ,   CATI Verification Scripts
Interview Verification	CATI Verification Scripts, CATI Verification Scripts, CATI Verification Scripts	CATI Verification Scripts ,   CATI Verification Scripts ,   CATI Verification Scripts
Follow-up Clinical Certification	CVS	CVS
Follow-up Clinical Interviews	CVS	CVS

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	459,793	218,980	0	240,813	0	0
Annual Time Burden (Hours)	219,105	79,852	0	139,253	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: Currently, there are 79,851 total burden hours in the OMB inventory. SAMHSA is requesting 81,882 burden hours for the main study. The inclusion of the additional questions on vaping and synthetics for 2020 will not result in a significant increase in main study respondent burden because these questions are closed-ended which typically take an average 10 seconds to administer, so most respondents will only see a minor increase. Additional information regarding changes in burden for the 2020 Clinical Validation Study is included in 2019 OMB addendum – CVS memo and for the 2020 Field Test is included in the 2019 OMB addendum – FT memo.

---

Annual Cost to Federal Government: $17,359,199

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 09/18/2019

---